GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – October 2010” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in September 2010. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days.

SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations.

In this report, our analysts reveal the company’s business strategy, strengths, weakness, opportunities and threats and detailed information such as :
- Key events associated with the company,
- Major products, services and brands of the company,
- Key competitors,
- Key executives, biographies and employment history,
- Personnel heading key departments and functions,
- Important locations and subsidiaries
- Financial analysis and ratios based on the annual financial statements published by the company including a 5 years history.
- Interim ratios for the last five interim periods

You get also in deepth information about operations to identify potential customers, partners and suppliers. business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Latest Company Developments:

Table Of Contents

1 Table of Contents 2
I. 1 List of Data tables 4
I. 2 List of Charts 6

II Deal Summary 8
II. 1 Pharmaceuticals and Healthcare, World Deals Analysis, September tember 2010 8
II. 2 Pharmaceuticals and Healthcare, Global, Top Deals, September tember 2010 10
II. 2.1 Johnson and Johnson To Take Over Additional Stake In Crucell 10
II. 2.2 Covance Concludes a New Deal With Sanofi-Aventis 10
II. 2.3 Amgen Announces Debt Offering Of US$ 1.5 Bln 10
II. 2.4 Endo Pharmaceuticals To Take Over Qualitest Pharmaceuticals 10
II. 2.5 Valeant Pharmaceuticals Prices Debt Offering Of US$ 1.2 Bln 11
II. 3 Pharmaceuticals and Healthcare, Global, by Type, Number of Deals and Deal Value, September tember 2010 12

III Pharmaceuticals and Healthcare, Merger and Acquisition Deal Summary, by Type 13
III. 1 Pharmaceuticals and Healthcare, Global, Merger and Acquisition, September tember 2010 13
III. 1.1 Top Merger and Acquisition Deals in September tember 2010 14
III. 1.2 Pharmaceuticals and Healthcare, World MandA Deals by Therapy Area, April il 2010 - September tember 2010 15
III. 2 Pharmaceuticals and Healthcare, Global, Equity Offering Deals, September tember 2010 16
III. 2.1 Top Equity Offering Deals in September tember 2010 17
III. 2.2 Pharmaceuticals and Healthcare, Global, Equity Offering Deals by Therapy Area, April il 2010 - September tember 2010 18
III. 3 Pharmaceuticals and Healthcare, Global, Debt Offering Deals, September tember 2010 19
III. 3.1 Top Debt Offering Deals in September tember 2010 20
III. 3.2 Pharmaceuticals and Healthcare, Global, Debt Offering Deals, by Therapy Area, April il 2010 - September tember 2010 21
III. 4 Pharmaceuticals and Healthcare, Global, Private Equity and Venture Capital Deals, September tember 2010 22
III. 4.1 Top PE/VC Deals in September tember 2010 23
III. 4.2 Pharmaceuticals and Healthcare, Global, PE/VC by Therapy Area, September tember 2010 24
III. 4.3 Pharmaceuticals and Healthcare, Global, Venture Capital Deals by Stage of Financing, September tember 2010 25
III. 4.4 Pharmaceuticals and Healthcare, Global, Top Venture Financing Firms, April il 2010 - September tember 2010 26
III. 4.5 Pharmaceuticals and Healthcare, Global, Top VC Backed Firms, April il 2010 - September tember 2010 27

IV Pharmaceuticals and Healthcare, Global, Partnership Deals, September tember 2010 28
IV. 1 Pharmaceuticals and Healthcare, Global, Partnership Deals, September tember 2010 28
IV. 2 Pharmaceuticals and Healthcare, Global, Partnership Deals by Therapy Area, April il 2010 - September tember 2010 29
IV. 3 Pharmaceuticals and Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Value (US$m), September tember 2010 30
IV. 3.1 Pharmaceuticals and Healthcare, Global, Top Partnership Deals by Payment Mode, September tember 2010 31
IV. 4 Pharmaceuticals and Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payment and Deal Value (US$m), April il 2010 - September tember 2010 32
IV. 5 Pharmaceuticals and Healthcare, Global, Partnership Deals by Phase, Number Of Deals and Deal Value (US$m), April il 2010 - September tember 2010 33
IV. 6 Pharmaceuticals and Healthcare, Global, Partnership Deals by Phase, by Upfront and Milestone Payment and Deal Value (US$m), April il 2010 - September tember 2010 34

V Pharmaceuticals and Healthcare, Global, Licensing Agreements, September tember 2010 35
V. 1 Pharmaceuticals and Healthcare, Global, Licensing Agreements, September tember 2010 35
V. 2 Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payment and Deal Value (US$m), September tember 2010 36
V. 2.1 Pharmaceuticals and Healthcare, Global, Top Licensing Agreements by Deal Value, September tember 2010 37
V. 2.2 Pharmaceuticals and Healthcare, Global, Top Licensing Agreements, by Total Upfront Payment, September tember 2010 37
V. 2.3 Pharmaceuticals and Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, September tember 2010 38
V. 3 Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Value (US$m), April il 2010 - September tember 2010 39
V. 4 Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payment and Milestone Payment (US$m), April il 2010 - September tember 2010 40
V. 5 Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Value (US$m), April il 2010 - September tember 2010 41
V. 6 Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payment and Milestone Payment (US$m), April il 2010 - September tember 2010 42

VI Deal Summary by Therapy Area 43
VI. 1 Pharmaceuticals and Healthcare, Oncology Deals, September tember 2010 43
VI. 1.1 Oncology - Deals of the Month 44
VI. 2 Pharmaceuticals and Healthcare, Central Nervous System Deals, September tember 2010 45
VI. 2.1 Central Nervous System - Deals of the Month 46
VI. 3 Pharmaceuticals and Healthcare, Immunology Deals, September tember 2010 47
VI. 3.1 Immunology - Deals of the Month 48
VI. 4 Pharmaceuticals and Healthcare, Infectious Disease Deals, September tember 2010 49
VI. 4.1 Infectious Diseases - Deals of the Month 50
VI. 5 Pharmaceuticals and Healthcare, Cardiovascular Deals, September tember 2010 51
VI. 5.1 Cardiovascular - Deals of the Month 52
VI. 6 Pharmaceuticals and Healthcare, Metabolic Disorders Deals, September tember 2010 53
VI. 6.1 Metabolic Disorders - Deals of the Month 54
VI. 7 Pharmaceuticals and Healthcare, Dermatology Deals, September tember 2010 55
VI. 7.1 Dermatology - Deals of the Month 56

VII Deal Summary by Geography 57
VII. 1 Pharmaceuticals and Healthcare, North America Region Deals, September tember 2010 57
VII. 1.1 North America - Deals of the Month 58
VII. 2 Pharmaceuticals and Healthcare, Europe Region Deals, September tember 2010 59
VII. 2.1 Europe - Deals of the Month 60
VII. 3 Pharmaceuticals and Healthcare, Asia-Pacific Deals, September tember 2010 61
VII. 3.1 Asia-Pacific - Deals of the Month 62
VII. 4 Pharmaceuticals and Healthcare, Rest of the World Deals, September tember 2010 63
VII. 4.1 Rest of the World - Deals of the Month 64

VIII Pharmaceuticals and Healthcare, Top Advisors 65
VIII. 1 Pharmaceuticals and Healthcare, World Top Financial Advisors, Merger and Acquisition, April il 2010 - September tember 2010 65
VIII. 2 Pharmaceuticals and Healthcare, Top Financial Advisors, Equity Offerings, April il 2010 - September tember 2010 66

IX Further Information 67
IX. 1 Methodology 67
IX. 2 About GlobalData 68
IX. 3 Contact Us 68
IX. 4 Disclosure information 68
IX. 5 Disclaimer 68
1.1 List of Data tables
Data table 1: Pharmaceuticals and Healthcare, Global, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 9
Data table 2: Pharmaceuticals and Healthcare, Global, Top Deals, September tember 2010 10
Data table 3: Pharmaceuticals and Healthcare, Global, Number Of Deals and Deal Value (%), September tember 2010 12
Data table 4: Pharmaceuticals and Healthcare, Global, Merger and Acquisition, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 13
Data table 5: Pharmaceuticals and Healthcare, Global, Top Merger and Acquisition Deals, September tember 2010 14
Data table 6: Pharmaceuticals and Healthcare, Global, Merger and Acquisition, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), by Therapy Area, April il 2010 - September tember 2010 15
Data table 7: Pharmaceuticals and Healthcare, Global, Equity Offerings, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 16
Data table 8: Pharmaceuticals and Healthcare, Global, Top Equity Offering Deals, September tember 2010 17
Data table 9: Pharmaceuticals and Healthcare, Global, Equity Offering Deals, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 18
Data table 10: Pharmaceuticals and Healthcare, Global, Debt Offering, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 19
Data table 11: Pharmaceuticals and Healthcare, Global, Top Debt Offering Deals, September tember 2010 20
Data table 12: Pharmaceuticals and Healthcare, Global, Debt Offering Deals, Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 21
Data table 13: Pharmaceuticals and Healthcare, Global, PE/VC, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 22
Data table 14: Pharmaceuticals and Healthcare, Global, Top PE/VC Deals, September tember 2010 23
Data table 15: Pharmaceuticals and Healthcare, Global, PE/VC Deals by Therapy Area, Merger and Acquisition Deal Summary, April il 2010 - September tember 2010 24
Data table 16: Pharmaceuticals and Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Value (%), September tember 2010 25
Data table 17: Pharmaceuticals and Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 26
Data table 18: Pharmaceuticals and Healthcare, Global, Top VC Backed Firms, April il 2010 - September tember 2010 27
Data table 19: Pharmaceuticals and Healthcare, Global, Partnerships, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 28
Data table 20: Pharmaceuticals and Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 29
Data table 21: Pharmaceuticals and Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Value (US$m), April il 2010 - September tember 2010 30
Data table 22: Pharmaceuticals and Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Value (US$m), September tember 2010 31
Data table 23: Pharmaceuticals and Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payment and Deal Value (US$m), April il 2010 - September tember 2010 32
Data table 24: Pharmaceuticals and Healthcare, Global, Partnership Deals by Phase, April il 2010 - September tember 2010 33
Data table 25: Pharmaceuticals and Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal Value (US$m), April il 2010 - September tember 2010 34
Data table 26: Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 35
Data table 27: Pharmaceuticals and Healthcare, Global, Licensing Agreements, Merger and Acquisition Deal Summary, Upfront and Milestone Payment and Deal Value (US$m), April il 2010 - September tember 2010 36
Data table 28: Pharmaceuticals and Healthcare, Global, Top Licensing Agreement Deals by Deal Value, September tember 2010 37
Data table 29: Pharmaceuticals and Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payment, September tember 2010 37
Data table 30: Pharmaceuticals and Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, September tember 2010 38
Data table 31: Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 39
Data table 32: Pharmaceuticals and Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payment (US$m), September tember 2010 40
Data table 33: Pharmaceuticals and Healthcare, Global, Partnership Deals by Phase, April il 2010 - September tember 2010 41
Data table 34: Pharmaceuticals and Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payment and Deal Value (US$m), September tember 2010 42
Data table 35: Pharmaceuticals and Healthcare, Global, Oncology, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 44
Data table 36: Pharmaceuticals and Healthcare, Global, Central Nervous System, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 46
Data table 37: Pharmaceuticals and Healthcare, Global, Immunology Diseases, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 48
Data table 38: Pharmaceuticals and Healthcare, Global, Infectious Diseases, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 50
Data table 39: Pharmaceuticals and Healthcare, Global, Cardiovascular, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 51
Data table 40: Pharmaceuticals and Healthcare, Global, Metabolic Disorders, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 54
Data table 41: Pharmaceuticals and Healthcare, Global, Dermatology, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 55
Data table 42: Pharmaceuticals and Healthcare, North America, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 58
Data table 43: Pharmaceuticals and Healthcare, Europe, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 60
Data table 44: Pharmaceuticals and Healthcare, Asia-Pacific, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 62
Data table 45: Pharmaceuticals and Healthcare, Rest of the World, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 63
Data table 46: Pharmaceuticals and Healthcare, Top Financial Advisors, Merger and Acquisition, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 65
Data table 47: Pharmaceutical and Healthcare, World Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 66
1.2 List of Charts
Chart 1: Pharmaceuticals and Healthcare, Global, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 8
Chart 2: Pharmaceuticals and Healthcare, Global, Number Of Deals (%) and Deal Value (%),September tember 2010 12
Chart 3: Pharmaceuticals and Healthcare, Global, Merger and Acquisition, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 13
Chart 4: Pharmaceuticals and Healthcare, Global, Merger and Acquisition by Therapy Area, Number of Deals and Deal Value (US$m), by Therapy Area, April il 2010 - September tember 2010 15
Chart 5: Pharmaceuticals and Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 16
Chart 6: Pharmaceuticals and Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 18
Chart 7: Pharmaceuticals and Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 19
Chart 8: Pharmaceuticals and Healthcare, Global, Debt Offering Deals, by Therapy Area, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 21
Chart 9: Pharmaceuticals and Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 22
Chart 10: Pharmaceuticals and Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Value (US$m), by Therapy Area, April il 2010 - September tember 2010 24
Chart 11: Pharmaceuticals and Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%) and Deal Value (%), September tember 2010 25
Chart 12: Pharmaceuticals and Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 26
Chart 13: Pharmaceuticals and Healthcare, Global, Partnerships, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 28
Chart 14: Pharmaceuticals and Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 29
Chart 15: Pharmaceuticals and Healthcare, Global, Partnership Deals, Upfront and Milestone Payment and Deal Value (US$m), April il 2010 - September tember 2010 30
Chart 16: Pharmaceuticals and Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payment and Deal Value (US$m), April il 2010 - September tember 2010 32
Chart 17: Pharmaceuticals and Healthcare, Global, Partnership Deals by Phase, April il 2010 - September tember 2010 33
Chart 18: Pharmaceuticals and Healthcare, Global, Partnership Deals by Phase, by Upfront and Milestone Payment and Deal Value (US$m), April il 2010 - September tember 2010 34
Chart 19: Pharmaceuticals and Healthcare, Global, Licensing Agreements, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 35
Chart 20: Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payment and Deal Value (US$m), April il 2010 - September tember 2010 36
Chart 21: Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 39
Chart 22: Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payment and Deal Value (US$m), April il 2010 - September tember 2010 40
Chart 23: Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals and Deal Value (US$m), April il 2010 - September tember 2010 41
Chart 24: Pharmaceuticals and Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payment and Deal Value (US$m), September tember 2010 42
Chart 25: Pharmaceuticals and Healthcare, Global, Oncology, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 43
Chart 26: Pharmaceuticals and Healthcare, Global, Central Nervous System, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 45
Chart 27: Pharmaceuticals and Healthcare, Global, Immunology, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 47
Chart 28: Pharmaceuticals and Healthcare, Global, Infectious Diseases, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 49
Chart 29: Pharmaceuticals and Healthcare, Global, Cardiovascular, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 51
Chart 30: Pharmaceuticals and Healthcare, Global, Metabolic Disorders, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 53
Chart 31: Pharmaceuticals and Healthcare, Global, Dermatology, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 55
Chart 32: Pharmaceuticals and Healthcare, North America, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 57
Chart 33: Pharmaceuticals and Healthcare, Europe, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 59
Chart 34: Pharmaceuticals and Healthcare, Asia-Pacific, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 61
Chart 35: Pharmaceuticals and Healthcare, Rest of the World, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 63
Chart 36: Pharmaceuticals and Healthcare, Top Financial Advisors, Merger and Acquisition, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 65
Chart 37: Pharmaceuticals and Healthcare, World Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$m), April il 2010 - September tember 2010 66

Companies mentioned

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Shadi

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers

Investment Opportunity in the Global Biofuels Energy Market

Investment Opportunity in the Global Biofuels Energy Market

  • $ 7 500
  • Industry report
  • April 2014
  • by Frost & Sullivan

The research service for the investment opportunity in biofuels energy focuses on the investments and funding patterns in global biofuels energy companies. The study identifies historical trends in bioethanol, ...

Vertical-Cavity Surface-Emitting Lasers (VCSEL) : Technologies and Global Markets

Vertical-Cavity Surface-Emitting Lasers (VCSEL) : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

The use of vertical-cavity surface-emitting lasers (VCSELs) has increased in the optical communications industry in the past 15 years. This spurring demand can be attributed to the increasing demand of ...

Merger and Acquisition Trends in the Global Food and Beverage Industry

Merger and Acquisition Trends in the Global Food and Beverage Industry

  • $ 6 000
  • Industry report
  • May 2014
  • by Frost & Sullivan

Average Deal Values are on the Rise This study analyzes the merger and acquisition (M&A) transactions that have taken place in the global food and beverage industry between January 2007 and December 2013. ...

Insight Report: Angel Investors

April 2014 $ 3 800

Telco Cdn

April 2014 $ 1 875

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.